Nuclear shrimp caution released in US
(MENAFN) The US Food and Drug Administration (FDA) has issued a warning advising consumers not to eat, sell, or serve certain frozen raw shrimp after traces of radioactive material were detected.
The contaminated product was imported by Indonesian company PT. Bahari Makmur Sejati (BMS Foods) and sold under Walmart’s Great Value brand in 13 states, including Texas, Florida, and Pennsylvania. While no tainted shrimp is confirmed to have reached store shelves, the FDA urged customers to act with caution.
“Anyone who recently purchased one of the affected lots of Great Value frozen shrimp should throw it away. Do not consume or serve this product,” the FDA said Tuesday, adding that distributors and retailers should immediately dispose of the shrimp.
The issue arose when US Customs detected cesium-137 in shipping containers at ports in Los Angeles, Houston, Savannah, and Miami. Subsequent FDA testing confirmed at least one sample of breaded shrimp carried the isotope. Although contamination levels were below the agency’s official intervention threshold, all suspect shipments were denied entry.
Walmart has since pulled the affected shrimp from its stores and urged customers to discard them or request a refund.
Cesium-137, a byproduct of nuclear fission, is known to damage DNA and raise cancer risks if ingested.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
